SCHEMBL13067944

SCHEMBL13067944

C=C(C)C1CCC(N(C)C)CC1

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 1/20 0.33
▸ ALOX15 P16050 1/20 0.31
▸ CYP1B1 Q16678 1/20 0.31
▸ L3MBTL3 Q96JM7 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11103446 0.81 LMNA (0.42) LMNAALOX15CYP1B1ALDH1A1
SCHEMBL9129884 0.81 — —
SCHEMBL513994 0.81 — —
SCHEMBL12412594 0.75 L3MBTL3 (0.38) L3MBTL3
SCHEMBL19733054 0.74 DRD2 (0.36) —
SCHEMBL613375 0.74 — —
SCHEMBL661220 0.74 TDP1 (0.42) L3MBTL3
SCHEMBL2467975 0.72 L3MBTL3 (0.33) L3MBTL3
Bromide SCHEMBL28409559 0.71 — —
Hydrochloric Acid SCHEMBL8936898 0.71 TDP1 (0.40) L3MBTL3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4289951-A2 CIRCULAR RNA COMPOSITIONS AND METHODS Orna Therapeutics, Inc. (US) 2023-12-13 — — EP disclosed
WO-2022112352-A1 HETEROCYCLE DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2022-06-02 — — WO disclosed
WO-2010129053-A2 EGFR INHIBITORS AND METHODS OF TREATING DISORDERS DANA FARBER CANCER INSTITUTE (US) 2010-11-11 — — WO disclosed
Send feedback